alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
**Exhibit 32.1**

 

**CERTIFICATION OF PRESIDENT AND CHIEFFINANCIAL OFFICER PURSUANT TO 18 U.S.C. SECTION 1350**

 

In connection with this Quarterly Report of KabeExploration, Inc. (the “Company”) on Form 10-Q for the periodending March 31, 2010, as filed with the Securities and ExchangeCommission on the date hereof (the “Report”), I, Erik Ulsteen, President, ChiefFinancial Officer and Secretary of the Company, certifies to the best of myknowledge, pursuant to 18 U.S.C. Sec. 1350, as adopted pursuant to Sec. 906 ofthe Sarbanes-Oxley Act of 2002, that:

 

1                            Such Quarterly Report on Form 10-Qfor the quarter ending March 31, 2010, fully complies with therequirements of section 13(a) or 15(d) of the Securities Exchange Actof 1934; and

 

2                            The information contained in suchQuarterly Report on Form 10-Q for the quarter ending March 31,2010, fairly presents, in all material respects, the financial condition andresults of operations of the Company.

 
| Date: May 14, 2010 |   |
|-------------------------|--------|
| /s/  Erik Ulsteen       |   |
| Erik Ulsteen            |   |
| President               |   |
| Chief Financial Officer |   |
| Secretary               |   |

 

----
EXHIBIT 31.1






CERTIFICATION PURSUANT TO 18 U.S.C. § 1350,


AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002






I, Dr. Samuel S. Asculai , certify that:




1. I have reviewed this quarterly report on Form 10-Q of Enhance Skin Products Inc;




2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;




3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;




4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:




(a)   Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period
in which this report is being prepared;




(b)   Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and




(c)   Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially
affect, the registrant's internal control over financial reporting; and




5. The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):




(a)   All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and




(b)   Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.






By:
/s/ Dr. Samuel S. AsculaiDate: September 21, 2009

Dr. Samuel S. AsculaiPresident & Chief Executive Officer
<PAGE>   1
                                                                  EXHIBIT 10.14



                    MAC FRUGAL'S BARGAINS O CLOSE-OUTS INC.

                               AMENDMENT NO. 2 TO
                  STOCK OPTION PLAN FOR NON-EMPLOYEE DIRECTORS




                 This Amendment No. 2 to the Stock Option Plan for Non-Employee
Directors (the "Plan") of MacFrugal's Bargains o Close-outs Inc., a Delaware
corporation (the "Company"), is made as of this 11th day of December, 1996.
Capitalized terms used herein shall have the same meaning as ascribed to such
terms in the Plan, unless otherwise defined herein.

                 1.       The first sentence of Section 4(b) of the Plan is
                          hereby amended to read in its entirety as follows:

                 "(b)  Amount, Exercise Price and Exercisability of Grants in
                 Lieu of Annual Retainer Fees.  In addition to the grants made
                 pursuant to Section 4(a), each Director shall have the right,
                 exercisable on the date of the Annual Meeting at which such
                 Director is elected, including each Annual Meeting at which
                 such Director is re-elected (the "Annual Meeting Date"), to
                 make an irrevocable election to receive an Option in lieu of
                 100%, but not less than 100%, of the Director's Retainer (as
                 defined hereafter) for the succeeding year; provided, however,
                 that no Director shall have the right to make such election
                 with respect to the Annual Meetings to be held in 1997, 1998
                 or 1999."

                 2.       Except as set forth herein, the Plan is hereby
ratified and confirmed in all respects.
USAID Goenmenwde

Agency Intranet 

Email Announcement

Employee Perception

Satisfaction

"USAID's Staff Care has

helped me to be more

present and mindful in the

office."

-USAID Employee

USAID 68%

Goenmenwde 60%

Program Promotion

"My agency shares a

monthly work-life

newsletter reminding me

of what I can do to

support my team’s

wellness.”

-USAID Employee

How did you find

out about your

agency's EAP?

45% 24%

41% 32%

"Staff Care includes a blended

team ofsocial workers, fitness

centerstaff, contractors, customer

service hotline representatives,

implementing partners,

counselors, and program

managers all in one place . We

all work to promote and support

the well-being of our employees

and the well-being of their

families."

-USAID Staff Care

USAID Goenmenwde

Agey Spog

USAID’s Employee Assistance Program culture of well-being, performance, and

success is attributed to Staff Care’s engagement. Staff Care Champions are

comprehensive and integrated approach to volunteer Agency employees passionate

supporting its workforce. Staff Care about employee engagement, and

supports all USAID employees and their empowered to integrate well-being across

family members around the world. USAID's their operating units. Staff Care Champions

Staff Care promotes a range of programs engage employees and leaders as

and initiatives that strive for a 21st advocates at all levels of the organization,

Century work environment where its total strategically educating teams on how Staff

workforce feels valued. Other components Care services support and improve

of this holistic approach include wellness, employee performance and engagement.

work-life, and organizational resilience. This innovative method of promoting

Staff Care and engaging employees and

Staff Care plays a critical role in advancing management has been key to advancing the

the Agency’s overall mission and building a overall reputation of USAID's EAP.

The EAP at my workplace has a good reputation

40% 25%

USAID Goenmenwde

My agency encourages the use of the EAP

48% 38%
** **

** **

**EXHIBIT 31.1**

 

**CERTIFICATION**

 

I, James Fitzsimons, certify that:

 

1.     I have reviewed this QuarterlyReport on Form 10-Q of Petrocorp Inc.

2.     Based on my knowledge, this reportdoes not contain any untrue statement of a material fact or omit to state amaterial fact necessary to make the statements made, in light of thecircumstances under which such statements were made, not misleading withrespect to the period covered by this report;

3.     Based on my knowledge, thefinancial statements, and other financial information included in this report,fairly present in all material respects the financial condition, results ofoperations and cash flows of the registrant as of, and for, the periodspresented in this report;

4.     I am responsible for establishingand maintaining disclosure controls and procedures (as defined in Exchange ActRules 13a-15(e) and 15d-15(e)) for the small business issuer and have:

(a)Designed such disclosure controls and procedures, or caused such disclosurecontrols and procedures to be designed under my supervision, to ensure thatmaterial information relating to the small business issuer, including itsconsolidated subsidiaries, is made known to me by others within those entities,particularly during the period in which this report is being prepared;

(b)Evaluated the effectiveness of the small business issuer’s disclosure controlsand procedures and presented in this report my conclusions about theeffectiveness of the disclosure controls and procedures, as of the end of theperiod covered by this report based on such evaluation; and

(c)Disclosed in this report any change in the small business issuer’s internalcontrol over financial reporting that occurred during the small businessissuer’s most recent fiscal quarter (the small business issuer’s fourth fiscalquarter in the case of an annual report) that has materially affected, or isreasonably likely to materially affect, the small business issuer’s internalcontrol over financial reporting; and

5.   I have disclosed, based on my mostrecent evaluation of internal control over financial reporting, to the smallbusiness issuer’s auditors and the audit committee of the small businessissuer’s board of directors (or persons performing the equivalent functions):

(a)All significant deficiencies and material weaknesses in the design or operationof internal control over financial reporting which are reasonably likely toadversely affect the small business issuer’s ability to record, process,summarize and report financial information; and

(b)Any fraud, whether or not material, that involves management or other employeeswho have a significant role in the small business issuer’s internal controlover financial reporting.

 

Date:November 16, 2009

                                                                                    /s/ James Fitzsimons

 James Fitzsimons, President
Office of Personnel Management

Retirement and Insurance Group

1920 1954 1959 

 

1986 

Benefits Administration Letter

Number: 95-701 Date: February 17, 1995 

SUBJECT Miscellaneous: Opportunity to Order Retirement and

Insurance Publications

Attached is the February 1995 rider listing the retirement and insurance publications that are available

for ordering. Please note that the form will be used for assignment of FEGLI (RI 76-10) is available

for ordering, as well as new pamphlets on reemployment of annuitants.

The cutoff date for submitting orders is March 31.

 

Mary M. Sugar, Chief

Agency Services Division

Office of Retirement Policy Division

Attachment
blue-ex1021_181.htm



[***] INDICATES MATERIAL THAT HAS BEEN OMITTED AND FOR WHICH CONFIDENTIAL TREATMENT HAS BEEN REQUESTED. ALL SUCH OMITTED MATERIAL HAS BEEN FILED WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO RULE 24b-2 PROMULGATED UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED.

 

Exhibit 10.21

September 29, 2017

Jason F. Cole, Esq.

bluebird bio, Inc.

50 Second St., Third Floor

Cambridge, MA 02141

Re: Extension of Term for Right of First Offer

Dear Mr. Cole:

Reference is hereby made to that certain License Agreement dated August 13, 2014 (the “License Agreement”) by and between Biogen MA Inc., a corporation organized and existing under the laws of Massachusetts, having its principal place of business at 250 Binney Street, Cambridge, Massachusetts 02142, USA (“Biogen”) and bluebird bio, Inc., a corporation organized and existing under the laws of Delaware, having its principal place of business at 50 Second Street, Third Floor, Cambridge, MA 02141, USA (“Bluebird”). Any capitalized terms not defined herein shall have the meaning set forth in the License Agreement.

Biogen and Bluebird agree as follows:

The term of Right of First Offer as described in Section 4.1 is hereby extended to [***]. All other terms and conditions of Section 4 shall apply with full force and effect during this extended term and are deemed not to have been lapsed or expired during the period of [***] to the date of this letter.

If you accept this extension, please so indicate by executing a copy of this letter and returning it to Biogen. Upon execution by both Bluebird and Biogen, this letter shall be considered part of the License Agreement, and, except as expressly provided above, shall not be deemed to modify or amend any other provision of the License Agreement. All other provisions of the License Agreement will remain in full force and effect.

This letter may be executed in counterparts, each of which will be deemed an original, notwithstanding variations in format or file designation which may result from electronic transmission, storage and printing of copies of this Amendment from separate computers or printers. Facsimile signatures and signatures transmitted via electronic mail in PDF format will be treated as original signatures.

[Signature page follows]

 

 

1



[***] INDICATES MATERIAL THAT HAS BEEN OMITTED AND FOR WHICH CONFIDENTIAL TREATMENT HAS BEEN REQUESTED. ALL SUCH OMITTED MATERIAL HAS BEEN FILED WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO RULE 24b-2 PROMULGATED UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED.

 

Sincerely,

 

/s/ John McDonald

 

John McDonald

VP, Business Development

BIOGEN MA, INC.

AGREEO TO AND CONFIRMED BY bluebird bio, INC.

By:  /s/ Jason F. Cole

Name:  Jason F. Cole

Title:  Chief Legal Officer

Date:  September 29, 2017

 

2
Exhibit 32.2








CERTIFICATIONS PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (18 U.S.C. SECTION 1350)






--------------------------------------------------------------------






In connection with the Quarterly Report of Consolidation Services, Inc. (the "Company") on Form 10-Q for the period ended March 31, 2010 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Pamela Thompson, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:




(1)           The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and




(2)           The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.









Registrant



Date: May 17, 2010

Consolidation Services, Inc.



By: /s/ Pamela ThompsonPamela ThompsonChief Financial Officer (Principal Financial Officer,)
Exhibit 15.1



Consent of Independent Registered Public
Accounting Firm



We consent to the incorporation by reference in the following
Registration Statement:



| | 1) | Registration Statement (Form F-3ASR No. 333-196187) of Grupo Financiero Santander México, S.A.B. de C.V.
| | -- | --------------------------------------------------------------------------------------------------------



of our reports dated April 18, 2016, relating to
the consolidated financial statements and financial statement schedules of Grupo Financiero Santander México, S.A.B.
de C.V., and the effectiveness of Grupo Financiero Santander México, S.A.B. de C.V.'s internal control over financial
reporting, included in this Annual Report on Form 20-F for the year ended December 31, 2015.



Mexico City, Mexico



May 2, 2016



|                                          
|------------------------------------------
|/s/ Galaz, Yamazaki, Ruiz Urquiza, S.C.   
|                                          
|                                          
|Galaz, Yamazaki, Ruiz Urquiza, S.C.       
|Member of Deloitte Touche Tohmatsu Limited
1

In The

Court of Appeals

Ninth District of Texas at Beaumont

________________

NO. 09-17-00405-CR

________________

TONYA ANN VALLOT, Appellant

V.

THE STATE OF TEXAS, Appellee

__________________________________________________________________

On Appeal from the Criminal District Court

Jefferson County, Texas

Trial Cause No. 17-26987

__________________________________________________________________

MEMORANDUM OPINION

In an open plea, Tonya Ann Vallot pleaded guilty to felony driving while 

intoxicated.1 The trial court found that the evidence substantiated Vallot’s guilt and 

sentenced Vallot to ten years of confinement. 

Vallot’s appellate counsel filed an Anders brief that presents counsel’s 

professional evaluation of the record and concludes that the appeal is frivolous. See 

 1

The record reflects that Vallot pleaded “true” to two prior convictions for 

driving while intoxicated.
2

Anders v. California, 386 U.S. 738 (1967); High v. State, 573 S.W.2d 807 (Tex. 

Crim. App. 1978). On March 7, 2018, we granted an extension of time for Vallot to 

file a pro se brief. We received no response from Vallot. We have reviewed the 

appellate record, and we agree with counsel’s conclusion that no arguable issues 

support the appeal. Therefore, we find it unnecessary to order appointment of new 

counsel to re-brief the appeal. Cf. Stafford v. State, 813 S.W.2d 503, 511 (Tex. Crim. 

App. 1991). We affirm the trial court’s judgment.2

AFFIRMED.

______________________________

 STEVE McKEITHEN

 Chief Justice

Submitted on June 26, 2018

Opinion Delivered July 25, 2018

Do Not Publish

Before McKeithen, C.J., Horton and Johnson, JJ.

 2 Vallot may challenge our decision in this case by filing a petition for 

discretionary review. See Tex. R. App. P. 68.
Exhibit








Exhibit 10.3
KADANT INC.
NOTICE OF AMENDMENT TO
RESTRICTED STOCK UNIT AWARD AGREEMENTS


1.    This amendment is effective as of September 20, 2017 with respect to the Restricted Stock Unit Award Agreements granted to the Recipient named below on the dates specified (the “Agreements”) and has been authorized and approved by the Compensation Committee of the Board of Directors of Kadant Inc. (the “Company”). 


Recipient:             Sandra L. Lambert


Performance-based RSU Award Agreement dated:    March 8, 2016
    
Time-based RSU Award Agreement dated:        March 8, 2016
    
Performance-based RSU Award Agreement dated:    March 8, 2017


Performance-based RSU Award Agreement dated:    March 8, 2017


2.    The following paragraph is added to (i) the end of Section 3(a) of the Performance-based RSU Award Agreements specified above in Section 1 and (ii) the end of Section 3 of the Time-based RSU Award Agreement specified above in Section 1:


“Reference is hereby made to the Executive Transition Agreement dated as of September 20, 2017 by and between you and the Company (the “Executive Transition Agreement”). Notwithstanding anything to the contrary in this Award Agreement, any Award Shares that would otherwise vest after March 10, 2018 (if employment continued) shall be fully vested and result in a distribution of the Award Shares as soon as practicable following the Separation Date (as defined in the Executive Transition Agreement) but no later than March 10, 2019 (the “Distribution Date”) provided that you have remained an employee of the Company until July 1, 2018 or your termination of employment otherwise satisfies Section 4.1(e) of the Executive Transition Agreement (subject in either case to providing an effective release, except where the vesting is caused by your death, on the terms set forth in Section 4.5(e) and the last paragraph of Section 4.5).”


3.    By your signature below, you acknowledge receipt of this Notice of Amendment to the Agreements and agree that this Amendment is attached and made a part of the Agreements, effective as of the 20th day of September, 2017.
    
RECIPIENT


/s/ Sandra L. Lambert
Sandra L. Lambert
_________________________________________ 

 

 

Order Michigan Supreme Court 

Lansing, Michigan 

April 28, 2006 Clifford W. Taylor,

 Chief Justice 

Michael F. Cavanagh 

Elizabeth A. Weaver 130184 

Marilyn Kelly 

Maura D. Corrigan 

Robert P. Young, Jr. 

Stephen J. Markman, PEOPLE OF THE STATE OF MICHIGAN, Justices 

Plaintiff-Appellee, 

v SC: 130184 

 COA: 256442 

Oakland CC: 03-193461-FH 

JOHNIE BERNARD WILLIAMS, 

Defendant-Appellant. 

_________________________________________/ 

On order of the Court, the application for leave to appeal the November 17, 2005 

judgment of the Court of Appeals is considered, and it is DENIED, because we are not 

persuaded that the questions presented should be reviewed by this Court. 

d0424 

I, Corbin R. Davis, Clerk of the Michigan Supreme Court, certify that the 

foregoing is a true and complete copy of the order entered at the direction of the Court. 

April 28, 2006 

Clerk